Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pliant Therapeutics Inc 331 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 USA

pliantrx.com Employees: 171 P: 650-481-6770

Sector:

Medical

Description:

Pliant Therapeutics Inc. is a late-stage biopharmaceutical company which involved in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. The company's lead product candidate includes bexotegrast. Pliant Therapeutics Inc., formerly known as PLANT THERAPEUT, is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 81,113
Enterprise Value, $K 40,133
Shares Outstanding, K 61,449
Annual Sales, $ 0 K
Annual Net Income, $ -210,300 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -26,300 K
EBIT, $ -186,120 K
EBITDA, $ -181,480 K
60-Month Beta 1.29
% of Insider Shareholders 8.00%
% of Institutional Shareholders 97.30%
Float, K 56,533
% Float 92.00%
Short Volume Ratio 0.10

Growth:

1-Year Return -90.87%
3-Year Return -92.94%
5-Year Return -94.82%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.43 on 11/06/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -2.88
EPS Growth vs. Prev Qtr 39.44%
EPS Growth vs. Prev Year 54.74%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PLRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -71.51%
Return-on-Assets % -53.26%
Profit Margin % 0.00%
Debt/Equity 0.15
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.39
Book Value/Share 3.26
Interest Coverage -68.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar